Skip to content

The Actual News

Stay informed without the news wearing you out.

Full coverage

The White House withdrew Heidi Overton’s nomination to lead the FDA ahead of a scheduled Senate committee vote.

The White House said Overton lacked enough congressional support to advance her confirmation. Several outlets reported that the Senate health committee had planned to vote on her nomination Wednesday.

What the reports agree on

  • The White House withdrew Overton’s nomination to lead the FDA. Axios, The Hill, ABC News, CBS News and 1 more
  • The Senate health committee had scheduled a vote on her nomination for Wednesday. Axios, The Hill, CBS News
  • Republican senators had raised concerns or doubts about Overton’s nomination. Axios, The Hill, ABC News, Guardian World

Where reports differ

  • The Hill reported that Republicans held a one-vote majority on the Senate health committee. The Hill
  • Guardian World reported that Overton needed all 12 committee Republicans to support her nomination to advance, while Democrats held 11 seats. Guardian World

Reported by one outlet

  • The White House said Overton did not have enough support in Congress to advance her confirmation. Axios
  • Overton faced Republican concerns about her positions on abortion, vaccines and vaping. ABC News
  • Administration officials confirmed the withdrawal. CBS News
  • Overton wrote in a 2023 policy brief that Congress should strictly regulate mifepristone. Guardian World

The original reports

The week's biggest stories, one calm email every Monday.